Interestingly, the majority of DMGs have higher deleterious mutation scores in the classes with poor prognosis (ER-, PR-, HER2+, grade III, and stage III), which suggests that the deleterious gene mutations are gradually accumulated with the progression of cancer. This evidence concerns the gene ESR1 and cancer.